| Tag | Content |
|---|
EnhancerAtlas ID | HS026-03098 |
Organism | Homo sapiens |
Tissue/cell | CNCC |
Coordinate | chr1:224031330-224033350 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Arid5a | MA0602.1 | chr1:224032195-224032209 | TATTTCAATATTGG | - | 6.61 | | Crx | MA0467.1 | chr1:224032749-224032760 | CTAATCCTCTC | - | 6.02 | | SOX10 | MA0442.2 | chr1:224032919-224032930 | AAAACAAAGCA | + | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09755 | chr1:224031350-224035269 | CD14 | | SE_18793 | chr1:224029943-224035230 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19882 | chr1:224031522-224035018 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AGTACATCAA GGCAATTGTC TACATTCTGA GACTATCCAT TTTTTTACAC TAAATGGCTT 60
TTCCTGATAA ATTGGTTAGA ATTTTCCAAA GCAATGTAAC AAAATTACAT TTATGTTGGA 120
ATAAAAATCC AAGCATATGA AAAGCCAAAG ATGAGAAATA TACTTAATAA AAGTTTTATT 180
TTCAAATATC CAAAATATTA CAGTATAAAG ACACATATAA CATGAGTCTA CTAAATGAAA 240
AATTATTTCA TATTTTTATA TATCACAAAT CTGAGAATCT CCACTTTAAC CAACATTGGA 300
AATTCAGAGG CGTTTATCTA CCGCCTATTG CAAGCTAGAC ACTGTACTAA TCACACTTCC 360
TTCATAAACA TAACTCTAAT CCTCAAACCA CCCTAAGAGC TGAGTACTAT TATCCCCATT 420
TTACAGATGA TGAAACTGAG GGACAAGTTT TTTTTAAGTG GCTACGTCAC TAAAGGTAGT 480
AGCTGAGCAA TACTGAAGTG TTAGTCTGAC TTCAAAGCTG GTGTAAGTGC CATCATACCA 540
CACTGAGTCT GTGTTAGGAT TGTATTCTGA CATCAGAAAG GCAATCAGAA GAACCATACT 600
GCTAAATTGA ATATAGTCTC AAGAGCCACA TAACGTTTTA TGAATTCGGC TACACAACGG 660
ATACCTTGGT AGGGTATCTC CAAAGGATAC CTTGACAAAA AACAAGGAAG AAACCATATA 720
GCAACAACTG ATACGTGTTT CTCTTGCTCC TACTGTTAGG AAAAATTCAC AGACAATCCG 780
TACAAGTTAC TTCAACACAA AGAAATGTAA ATCCAGGAAA TAAAAATCTT AACAGCAAAA 840
TCCATCACCC TTATCTATGG TCCATTATTT CAATATTGGG TATTCACACT ACAAACCTGA 900
TTTCATAACC AGGCATTAAA CTAAAATAAG ATGCATAATG CTATTAATAC TTTCAAATTC 960
CTTGAATCCT GGCAGGACAA AATATCCCAA ACCCTCTAAA CCCAATTACT AATTCTAGTG 1020
AATTGTTAAG TCGACCCAGT GAGAGTTTGG GACGCCCTCC ATGACACAAG CAGGGGGCCA 1080
GGGAACAGCA TATTATACTC TGTATGTATG ACTGCAAACT TTGTCATCAC TCCATTCCAC 1140
AGACTTCATA AAAGTAAAAG CTTTTTGTTT CTTTGTCTGA ACAAATGGAG CCACAAGCAT 1200
AGGATGCCTG CAAGATGTCC CCACTTCAGT GGGAGAGGTG CAAATACAAC TTCCACGAAG 1260
AAACTCGCTA CTGAAGTCTG CAGAAGCCAC CGCAACACAC CGCAAACCTC CATTCCGCGA 1320
TCGCTGAATG ACAGAGACAT TTCTGAAATG TCTCAAACCT GCTGTTCATC TGTGGCCTGG 1380
TGGCCGTGTC AAAAGCCTGC GGAGCTCCTA AAGAAGGCAC TAATCCTCTC CGGAGGTCTT 1440
GCTAAAAGCT GTGGGAAACG AAGGGAGCCA GGCACGTACG CTTTCCTGCA ATCTAAAACT 1500
TCCGAGATTG CATTTACCAA AACCCCTTTC CACAAAGAGG TAAGGGTGAC TTAGCTGCTA 1560
CTGTGGATAT CAAGATCGAA ATTCAATTAA AAACAAAGCA AAGGTACCCG TTCCAGTAAC 1620
GTATGTTTCA CTCCAGTAAA AAGTAAAAAG ACACAGCAAA GAACAAGGTC CCCGGTTCCC 1680
GTATTCTTGA CCTTCAAGAA CTGCAAAAAA GTCAAGACCC AGTGAAAGAC GAAAAGTTTG 1740
AGTGGCTGCT GGGCTCGCGG GCGGCTCGCC TGACTCCGGA GCAGCTGGAG GAACCCGCCT 1800
CGAGGTTAGG GTCTCGCCGC GCCCCCACGA CGGCTGTGGG CGCAGAGCCC AGAGGATGGA 1860
GCCTCCCCTT CCTGAAACCC GCTCGAAGCT CGGAAAGCCC CGGCCCCTCC GCGCGGGCTG 1920
CGGCCCCCAG GCTCCTTCCC CGACGCGCCC GAGGGCGCGG ACCAGCCCCC GGCACGCGAC 1980
CCCGCACACT TCCGGGCCCG ACGCCCTGGC CGCTCGCCCA 2020
|
